The country is reportedly planning to let commercial banks create venture capital units to invest in technology startups.
Month: February 2016
BeiGene cracks IPO code for $158m
The China-based immuno-oncology company, backed by Merck & Co since 2011, floated at the top of it range and has gained since its debut yesterday.
Knewton recalculates series F to reach $52m
Asian investors Tal Education and EDBI added $10m to the $42.3m series F round initially closed by Pearson-backed learning materials provider Knewton in November.
Digital Asset gets bigger, raising $60m
IBM and Goldman Sachs invested $10m in the blockchain technology startup, which raised $50m from 13 corporate investors last month.
Sanara Ventures reveals first-year portfolio
The Philips-Teva joint venture has supplied four companies with upwards of $1m in funding as part of its incubator program.
Wonolo raises $5.7m to meet funding demand
The on-demand staffing platform, a graduate of the Coca-Cola Founders scheme, has raised $5.7m from undisclosed investors.
WebRadar picks up Qualcomm for $10m round
Qualcomm Ventures and DGF Investments provided $10.1m for the big data technology company, which already counted Intel and Citrix as investors.
KFit tones up with $12m
SIG and Axiata were among the investors as fitness services app developer KFit raised $12m to help it expand further in the Asia Pacific region.
WeDoctor gets $20m check up
WeDoctor Group, the Tencent and Fosun-backed online health services company formerly known as Guahao, has received $20m from Shandong Tyan Home.
Flyby Media jets to Apple
Flyby Media, US-based virtual reality (VR) technology producer backed by corporates Clark Enterprises and Robert Bosch, has been acquired by technology company Apple for an undisclosed sum, according to VentureBeat. Founded in 2008, Flyby has developed a smartphone app that is able to map a real-world space. The company was originally named Arballon, before rebranding… Continue reading Flyby Media jets to Apple
Osborn to take MD role at Telus Ventures
Richard Osborn is leaving his managing director role at healthcare investment fund RecapHealth Ventures for a similar role at CVC unit Telus Ventures.
Editas raises $94m in 2016’s first US IPO
Genome editing company Editas, backed by Alphabet and Partners Healthcare, has secured $94.4m, pricing the initial public offering at the bottom of the $16 to $18 range.
Proteostasis to move for IPO
The company could secure up to $60.8m in proceeds, having previously raised equity and debt from investors such as Novartis, Sanofi and Elan Science One.
Investors put together $86m for funding Mission
Existing backers including GlaxoSmithKline and Roche were joined by Pfizer and Woodford Patient Capital for the Cambridge spinout’s series C round.